NCT06409442 Effects of Corrective External Support and Regional Vibration Applications in Subacromial Pain Syndrome
| NCT ID | NCT06409442 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dokuz Eylul University |
| Condition | Subacromial Pain Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 63 participants |
| Start Date | 2024-06-24 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 63 participants in total. It began in 2024-06-24 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sixty three individuals with chronic subacromial pain syndrome will be included in our study. In the evaluations to be made to the participants; Pain intensity will be measured with the Visual Analogue Scale (VAS), joint movement and shoulder proprioception will be measured with the inclinometer, and shoulder muscle strength will be measured with the digital hand dynamometer. In addition, functionality and disability levels will be determined by SPADI and Short form-Questionnaire for Arm, Shoulder and Hand Problems (Q-DASH). Supraspinatus tendon thickness and acromiohumeral space measurements will be made by ultrasonographic imaging. Patient satisfaction will be evaluated with the Visual Analog Patient Satisfaction Scale survey and quality of life will be evaluated with the SF-12 survey (The 12-item Short Form Survey). Participants will be randomly divided into 3 groups of 21 participants each. In addition to the standard physiotherapy program, taping around the shoulder will be applied to the kinesio taping group, and localized vibration therapy around the shoulder will be applied to the localized vibration therapy group, in addition to the standard physiotherapy program. The Control Group (CG) will receive the same physiotherapy program as the other groups and will attend the same number of sessions as the other groups, accompanied by a physiotherapist. Evaluations will be made and analyzed before treatment, after 3 weeks of treatment, after 6 weeks of treatment, at 12 weeks and at the end of 24 weeks.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the study, * Being over 18 years of age, * Having diagnosed with subacromial impingement syndrome, * SIS-related complaints have persisted for at least 3 months, * Not having received any treatment for shoulder problems in the last 6 months, * No history of shoulder injury other than subacromial impingement and/or shoulder symptoms requiring treatment for the last 1 year, * To be able to read and write Turkish in order to complete all evaluations and applications in the study and to carry out evaluations that require reading and writing. Exclusion Criteria: * Having a history of fractures and surgery in the upper extremity and cervicothoracic region, * Having another neurological, orthopedic or rheumatic shoulder problem such as frozen shoulder or instability, * Having a systemic musculoskeletal disease, * Known chest deformity, scoliosis diagnosis and physical disability, * Presence of a skin problem or a condition that may be a contraindication to the application in the area where KT or LVT will be applied.
Contact & Investigator
Sevgi Sevi Yeşilyaprak, PhD
STUDY DIRECTOR
Dokuz Eylul University
Frequently Asked Questions
Who can join the NCT06409442 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Subacromial Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06409442 currently recruiting?
Yes, NCT06409442 is actively recruiting participants. Contact the research team at ssyesilyaprak@gmail.com for enrollment information.
Where is the NCT06409442 trial being conducted?
This trial is being conducted at Izmir, Turkey (Türkiye).
Who is sponsoring the NCT06409442 clinical trial?
NCT06409442 is sponsored by Dokuz Eylul University. The principal investigator is Sevgi Sevi Yeşilyaprak, PhD at Dokuz Eylul University. The trial plans to enroll 63 participants.